Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome
- PMID: 10414734
- DOI: 10.1016/s0090-4295(99)00040-0
Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome
Abstract
Objectives: To determine the feasibility of contrast-enhanced three-dimensional (3D) imaging of the prostatic vasculature using power Doppler imaging and to analyze whether semiquantitative judgments of 3D images with respect to symmetry and distribution of vascular structures correlated with biopsy outcome.
Methods: 3D power Doppler images were obtained before and after intravenous administration of 2.5 g Levovist. Subsequently, random and/or directed transrectal ultrasound (TRUS)-guided biopsies were performed. Vascular images were analyzed by two experts. Prostate vasculature was judged with respect to symmetry and vessel distribution using a (scale) grading system.
Results: Eighteen patients with a suspicion of prostate cancer either because of an elevated prostate-specific antigen (greater than 4.0 ng/mL; Tandem-R-assay) or an abnormal digital rectal examination were included in the study. Prostate cancer was detected in 13 patients. Vascular anatomy was judged abnormal in unenhanced images in 6 cases, of which 5 proved malignant. Enhanced images were considered suspicious for malignancy in 12 cases, including 1 benign and 11 malignant biopsy results. Sensitivity of enhanced images was 85% (specificity 80%) compared with 38% for unenhanced images (specificity 80%) and 77% for conventional gray-scale TRUS (specificity 60%). Of 6 patients who showed no B-mode abnormalities, vascular patterns were judged abnormal in 4 cases, of which 3 were malignant.
Conclusions: Contrast-enhanced 3D power Doppler angiography is feasible in patients with suspicion of prostate cancer who are scheduled for prostate biopsies. The sensitivity of power Doppler 3D imaging for the detection of prostate malignancy increased from 38% (5 of 13) to 85% (11 of 13) after administration of intravascular microbubble contrast (Levovist), and specificity was found to be 80% (4 of 5) for both imaging modalities. Thus, the use of Levovist when combined with the power Doppler display mode and 3D image reconstruction offers a promising new research area that might prove useful in prostate cancer detection in the future.
Similar articles
-
Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.Clin Radiol. 2016 Mar;71(3):258-64. doi: 10.1016/j.crad.2015.11.013. Epub 2015 Dec 28. Clin Radiol. 2016. PMID: 26738964
-
Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.BJU Int. 2011 Dec;108(11):1723-7. doi: 10.1111/j.1464-410X.2011.10199.x. Epub 2011 Jul 14. BJU Int. 2011. PMID: 21756276 Clinical Trial.
-
Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer.BJU Int. 2000 Jul;86(1):58-64. doi: 10.1046/j.1464-410x.2000.00719.x. BJU Int. 2000. PMID: 10886084
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer.Urology. 2010 Nov;76(5):1025-33. doi: 10.1016/j.urology.2010.05.022. Epub 2010 Aug 16. Urology. 2010. PMID: 20719368 Review.
Cited by
-
[Imaging procedures to diagnose prostate cancer].Urologe A. 2007 Oct;46(10):W1435-46; quiz W1447-8. doi: 10.1007/s00120-007-1455-x. Urologe A. 2007. PMID: 17665166 German.
-
Three dimensional ultrasound and prostate cancer.World J Urol. 2004 Nov;22(5):339-45. doi: 10.1007/s00345-004-0417-9. Epub 2004 Nov 12. World J Urol. 2004. PMID: 15549322 Review.
-
Feasibility of functional imaging for brachytherapy.J Contemp Brachytherapy. 2009 Mar;1(1):45-49. Epub 2009 Mar 23. J Contemp Brachytherapy. 2009. PMID: 27799953 Free PMC article. Review.
-
Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.Urology. 2020 Apr;138:106-112. doi: 10.1016/j.urology.2019.12.025. Epub 2019 Dec 30. Urology. 2020. PMID: 31899231 Free PMC article.
-
[New ultrasound technologies for the diagnostics of prostate cancer].Radiologe. 2011 Nov;51(11):938, 940-6. doi: 10.1007/s00117-011-2178-y. Radiologe. 2011. PMID: 22083309 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical